P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
ACET | N/A | N/A | N/A | +15.19% |
ACET Peer | 6.9 | 4.4 | N/A | N/A |
Pharmaceuticals: Major Industry | 26.6 | 20.4 | 2.2 | -0.72% |
Health Technology Sector | 49.2 | 24.7 | 1.7 | -11.34% |
S&P 500 Market | 41.6 | 28.0 | 4.3 | +3.46% |
Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
---|---|---|---|---|
Mean Estimate | -$0.43 | -$0.72 | -$0.60 | -$0.71 |
Previous Mean | -$0.57 | -$0.72 | -$0.60 | N/A |
Standard Deviation | 0.74 | 0.15 | 0.31 | 0.22 |
Low Estimate | -$0.77 | -$0.83 | -$0.85 | -$0.86 |
High Estimate | $1.53 | -$0.41 | $0.15 | -$0.38 |